<DOC>
	<DOC>NCT00386555</DOC>
	<brief_summary>To determine the effectiveness of CP-868,596 + docetaxel, AG-013736 + docetaxel and CP-868,596 + AG-013736 + docetaxel in patients previously treated for non-small cell lung cancer.</brief_summary>
	<brief_title>A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Crenolanib</mesh_term>
	<mesh_term>Axitinib</mesh_term>
	<criteria>Platinumpretreated patients with advanced stage IIIb or IV NSCLC Centrallylocated tumors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>